SCHEMBL3289446

SCHEMBL3289446

CCCCOB(OCCCC)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PCSK9 Q8NBP7 1/20 0.52
LTA4H P09960 2/20 0.47
CYP1A2 P05177 3/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 5/20 0.40
TSHR P16473 4/20 0.40
TDP1 Q9NUW8 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CYP3A4 P08684 3/20 0.39
MAPK1 P28482 3/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
TRPM2 O94759 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
KMT2A Q03164 1/20 0.39
MLNR O43193 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30545060 0.92 PCSK9 (0.48) PCSK9LTA4HALDH1A1TSHRCYP3A4
SCHEMBL30545064 0.92 PCSK9 (0.48) PCSK9LTA4HALDH1A1TSHRCYP3A4
SCHEMBL11711998 0.92 PCSK9 (0.48) PCSK9LTA4HALDH1A1TSHRCYP3A4
SCHEMBL14983388 0.89 LTA4H (0.42) PCSK9LTA4HCYP1A2CYP2C9CYP2C19
SCHEMBL1677080 0.88 PCSK9 (0.42) PCSK9LTA4HCYP1A2CYP2C9CYP2C19
SCHEMBL7796509 0.87 MEN1 (0.42) PCSK9LTA4HCYP1A2ALDH1A1TSHR
SCHEMBL14983385 0.84 MGLL (0.44) PCSK9LTA4HCYP1A2CYP2C9CYP2C19
SCHEMBL14983499 0.84 CA1 (0.45) PCSK9LTA4HALDH1A1L3MBTL1HPGD
SCHEMBL7799309 0.83 TSHR (0.59) PCSK9LTA4HCYP1A2CYP2C9CYP2C19
SCHEMBL18304616 0.83 PCSK9 (0.41) PCSK9LTA4HCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0692033-A1 ENHANCEMENT OF CHEMILUMINESCENT REACTIONS BTG INTERNATIONAL LIMITED (GB) 1996-01-17 EP claimed
WO-2023038506-A1 COMPOSITION CONTAINING FOXTAIL EXTRACT AS ACTIVE INGREDIENT, AND USE THEREOF 경북대학교 산학협력단 2023-03-16 WO disclosed
US-8945820-B2 Silicon-containing resist underlayer film-forming composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-02-03 US disclosed
US-8945820-B2 Silicon-containing resist underlayer film-forming composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-02-03 US disclosed
US-20130137271-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-30 US disclosed
US-20130137271-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-30 US disclosed
US-8404731-B2 Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors TRANSTECH PHARMA, INC. (US) 2013-03-26 US disclosed
US-20120196906-A1 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors TRANSTECH PHARMA, INC. (US) 2012-08-02 US disclosed
US-7723369-B2 Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors TRANSTECH PHARMA, INC. (US) 2010-05-25 US disclosed
US-20100113331-A1 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PtPase Inhibitors TRANSTECH PHARMA, INC. (US) 2010-05-06 US disclosed
US-20050176987-A1 Method for producing vinyl, aryl and heteroaryl acetic acids and derivatives thereof STUDIENGESELLSCHAFT KOHLE MBH (DE) 2005-08-11 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed
EP-0808849-B1 Process for the production of ethylenic polymers SHOWA DENKO KK (JP) 2001-12-19 EP disclosed
US-6011127-A CATALYST COMPRISING A CHROMIUM COMPOUND, AN ALUMOXANE AND AN ORGANOMETALLIC ALKOXIDE AND/OR ORGANOMETALLIC SILOXIDE AND A CARRIER SUPPORTING THEREON THESE COMPOUNDS. SHOWA DENKO K.K. (JP) 2000-01-04 US disclosed
EP-0808849-A1 Process for the production of ethylenic polymers SHOWA DENKO KABUSHIKI KAISHA (JP) 1997-11-26 EP disclosed
EP-0626016-A1 CHEMILUMINESCENT ENHANCERS BTG INTERNATIONAL LIMITED (GB) 1994-11-30 EP disclosed
US-4933421-A QUICK-CURING SHELL OIL COMPANY (US) 1990-06-12 US disclosed
US-4085090-A Aromatic polymers containing a nitrogen-containing ring group, and process for preparation thereof TEIJIN LIMITED (JA) 1978-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176987-A1 Method for producing vinyl, aryl and heteroaryl acetic acids and derivatives thereof HDHD5, PAH, AHR PCSK9 4289/4885LTA4H 2481/4885CYP1A2 206/4885
US-20100113331-A1 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PtPase Inhibitors PTP4A1, PTPRJ, PTP4A2 PCSK9 1139/4885LTA4H 1653/4885CYP1A2 1218/4885
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A PCSK9 3742/4885LTA4H 3537/4885CYP1A2 1/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 PCSK9 3869/4885LTA4H 3535/4885CYP1A2 1/4885
US-20120196906-A1 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors PTP4A1, PTPRJ, PTP4A2 PCSK9 1139/4885LTA4H 1653/4885CYP1A2 1218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.